Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Accelerating Breakthrough Targeted New Therapies for Cardio-Renal Complications in People With T1D (Precision T1D Platform)

NCT07594145 is registered in ClinicalTrials.gov with Oregon Health and Science University as lead sponsor.

NCT NCT07594145
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07594145 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Accelerating Breakthrough Targeted New Therapies for Cardio-Renal Complications in People With T1D (Precision T1D Platform)
Lead sponsor
Oregon Health and Science University
Phase
Phase 2
Overall status
Not yet recruiting
Start date
November 1, 2026
Completion date
December 31, 2031
Enrollment
57 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cardio-renal vascular function and failure, diabetic chronic kidney disease, t1d heart failure, type 1 diabetes